SCHEMBL4245800

SCHEMBL4245800

CC[n+]1ccn(C)c1C.CS(=O)(=O)[O-]

nearest known ligand 0.30

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 2/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
MAPT P10636 1/20 0.30
POLB P06746 1/20 0.30
APOBEC3A P31941 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4245931 0.95 CTDSP1 (0.31) CTDSP1CA1CA2MAPTPOLB
Sulfuric Acid SCHEMBL21195039 0.93 CTDSP1 (0.30) CTDSP1CA1CA2MAPTPOLB
SCHEMBL1617828 0.93 CTDSP1 (0.30) CTDSP1CA1CA2MAPTPOLB
Sulfuric Acid SCHEMBL17102575 0.91 CA1 (0.33) CA1CA2
SCHEMBL28470575 0.88 PSMD14 (0.33) POLB
Trifluoromethanesulfonic Acid SCHEMBL1330266 0.87 KCNH2 (0.35) CTDSP1MAPT
SCHEMBL294563 0.87
SCHEMBL4247119 0.85 CA1 (0.43) CA1CA2MAPT
Fluoride Ion SCHEMBL1900591 0.85 CTDSP1 (0.35) CTDSP1CA1CA2MAPTPOLB
Bromide SCHEMBL710393 0.85 CA1 (0.39) CTDSP1CA1CA2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 EP claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
EP-1812382-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 EP claimed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 WO claimed
CN-111836849-B Process for producing fibers, films and moldings of polybenzazole polymer (P) 巴斯夫欧洲公司 2023-04-07 CN disclosed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP disclosed
CN-109790292-B Process for preparing polybenzazole polymer (P) 巴斯夫欧洲公司 2022-05-31 CN disclosed
US-11312852-B2 Method for preparing graft copolymer complex, graft copolymer complex, and thermoplastic resin composition comprising graft copolymer complex LG CHEM, LTD. (KR) 2022-04-26 US disclosed
CN-110198962-B Method for preparing graft copolymer composite, and thermoplastic resin composition comprising the same 株式会社LG化学 2022-01-07 CN disclosed
EP-3042939-B1 ADHESIVE COMPOSITION TOAGOSEI CO LTD (JP) 2021-06-23 EP disclosed
CN-109415602-B 2-cyanoacrylate-based adhesive composition 东亚合成株式会社 2021-05-25 CN disclosed
EP-3533810-B1 METHOD FOR PREPARING GRAFT COPOLYMER COMPLEX, GRAFT COPOLYMER COMPLEX, AND THERMOPLASTIC RESIN COMPOSITION COMPRISING THE GRAFT COPOLYMER COMPLEX LG CHEMICAL LTD (KR) 2021-04-21 EP disclosed
EP-3042933-A1 CURABLE RESIN COMPOSITION Toagosei Co., Ltd. (JP) 2016-07-13 EP disclosed
US-9353299-B2 2-cyanoacrylate-based adhesive composition TOAGOSEI CO., LTD. (JP) 2016-05-31 US disclosed
US-20150315426-A1 ADHESIVE COMPOSITION TOAGOSEI CO., LTD. (JP) 2015-11-05 US disclosed
EP-2933302-A1 ADHESIVE COMPOSITION Toagosei Co., Ltd (JP) 2015-10-21 EP disclosed
US-20150225627-A1 2-CYANOACRYLATE-BASED ADHESIVE COMPOSITION TOAGOSEI CO., LTD. (JP) 2015-08-13 US disclosed
EP-2896668-A1 2-CYANOACRYLATE-BASED ADHESIVE COMPOSITION Toagosei Co., Ltd (JP) 2015-07-22 EP disclosed
US-7897806-B2 Reacting primary amines with phosgene in ionic liquid as solvent BASF AKTIENGESELLSCHAFT (DE) 2011-03-01 US disclosed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES PGLS, INMT, PNMT CTDSP1 403/4885CA1 2478/4885CA2 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.